Guizhou Chanhen Chemical Corporation

SZSE:002895.SZ

18.36 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 1,399.3831,021.0921,247.9071,191.654881.556998.391991.89869.027978.043608.505858.872665.622618.318387.288495.414477.001462.532342.305433.045519.839473.584322.839316.252406.728346.615220.682290.157310.383345.408237.831212.463310.465281.217281.217
Cost of Revenue 974.281690.557691.257715.659598.387627.954551.536419.21533.807393.818667.364408.821449.362286.755401.638350.079335.636252.509317.372363.272336.539254.272258.372305.659276.955176.759234.217227.468246.585172.068164.383216.509200.985200.985
Gross Profit 425.102330.535556.649475.995283.17370.437440.354449.818444.235214.688191.507256.801168.956100.53393.776126.922126.89689.797115.673156.567137.04568.56757.881101.06869.65943.92355.9482.91698.82365.76348.07993.95680.23180.231
Gross Profit Ratio 0.3040.3240.4460.3990.3210.3710.4440.5180.4540.3530.2230.3860.2730.260.1890.2660.2740.2620.2670.3010.2890.2120.1830.2480.2010.1990.1930.2670.2860.2770.2260.3030.2850.285
Reseach & Development Expenses 22.5217.74335.20122.10426.72717.08757.53723.14919.08810.31513.26411.3988.4085.6396.16312.227.1327.0713.625-0.93513.1346.7555.3034.0110.5363.67422.8423.0649.017036.06702.6812.681
General & Administrative Expenses -27.665.893-126.298152.622-42.82975.116-105.687137.971-24.83741.898-78.818101.255-15.73824.016-42.14317.744-10.67919.483-52.49618.543-12.93918.659-50.07424.89-8.66614.758-30.39315.26114.04512.184-27.414.47713.35213.352
Selling & Marketing Expenses 23.46119.8125.37617.93514.22617.20926.16311.52710.84310.519-44.51829.53327.06928.26431.28426.46327.40724.43532.23534.48135.58125.91827.97928.2221.85718.2526.50720.00220.62917.47726.67918.10219.03219.032
SG&A 81.45486.023-100.922170.557-28.60392.325-79.524149.498-13.99452.416-123.335130.78811.33152.28-10.85844.20716.72843.918-20.26153.02422.64244.578-22.09553.1113.19133.008-3.88635.26334.67529.66-0.72132.57832.46932.469
Other Expenses -16.931-32.9-0.833-1.945-0.5818.425199.29-51.72896.35.346-1.555-0.132-0.14-0.648-0.697-0.117-0.262-0.495-2.223-2.411-0.462-0.407-3.464-0.1953.568-0.741-7.884-1.7344.274.2062.7122.07200
Operating Expenses 120.905136.666156.23131.475118.351127.837177.303120.92101.39468.077-3.345105.44887.6151.80186.83655.60755.40552.13560.01552.23575.85349.76532.41457.32750.61133.23244.69936.7536.15730.94251.1732.88638.2538.25
Operating Income 304.197193.87335.868297.591137.901199.874210.228304.013329.801125.167170.85136.01284.98646.533-3.45776.29272.84433.16246.082104.47765.62310.17121.61243.74826.8396.0314.4247.26663.85533.1983.04956.9646.32546.325
Operating Income Ratio 0.2170.190.2690.250.1560.20.2120.350.3370.2060.1990.2040.1370.12-0.0070.160.1570.0970.1060.2010.1390.0320.0680.1080.0770.0270.050.1520.1850.140.0140.1830.1650.165
Total Other Income Expenses Net -30.688-29.556-0.833-1.945-0.58-1.998-6.9-16.664-0.522-0.509-1.555-15.4733.499-0.648-11.0944.861.091-4.994-11.799-2.2663.97-9.038-7.319-0.18911.359-5.402-4.706-0.6345.4592.5827.69-2.038-6.485-6.485
Income Before Tax 273.509164.313335.035295.646137.322197.876203.328287.349329.279124.658169.294135.87984.84645.885-4.15476.17672.58232.66843.859102.06665.1629.76418.14843.55330.4075.2896.53645.53168.12437.4044.659.03239.8439.84
Income Before Tax Ratio 0.1950.1610.2680.2480.1560.1980.2050.3310.3370.2050.1970.2040.1370.118-0.0080.160.1570.0950.1010.1960.1380.030.0570.1070.0880.0240.0230.1470.1970.1570.0220.190.1420.142
Income Tax Expense 53.5536.37553.67364.71721.13737.46126.3658.06853.30918.3178.70220.70711.70210.232-3.93615.95714.7387.3316.29616.45813.7824.8647.96.7914.781.2731.4187.2119.6875.8661.4248.825.3675.367
Net Income 219.034134.641274.885218.19114.983158.347168.509218.663266.507104.1155.897107.270.55134.116-0.00559.79157.60625.22237.88385.82251.5915.10510.81136.76125.6264.0165.11738.32158.43831.5383.17550.21234.47334.473
Net Income Ratio 0.1570.1320.220.1830.130.1590.170.2520.2720.1710.1820.1610.1140.088-00.1250.1250.0740.0870.1650.1090.0160.0340.090.0740.0180.0180.1230.1690.1330.0150.1620.1230.123
EPS 0.410.250.560.440.240.320.340.450.550.210.320.220.150.07100.150.140.0630.0950.210.130.0130.0270.0920.0640.010.0140.110.160.0880.0090.140.0960.096
EPS Diluted 0.40.250.560.420.230.310.290.450.550.210.320.220.150.0700.150.140.0620.0950.210.130.0130.0270.090.0640.010.0140.110.160.0880.0090.140.0960.096
EBITDA 422.961235.435390.552339.251176.297241.487231.507326.773362.255147.145189.945155.80586.67448.98-5.04470.01276.54139.60347.506107.24470.04514.96231.63243.89121.23210.8615.43645.2777.11148.7460.66261.0759.90359.903
EBITDA Ratio 0.3020.2310.3130.2850.20.2420.2330.3760.370.2420.2210.2340.140.126-0.010.1470.1650.1160.110.2060.1480.0460.10.1080.0610.0490.0530.1460.2230.2050.0030.1970.2130.213